Related Experiment Video
Updated: Jan 4, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
miR-425 regulates cell proliferation, migration and apoptosis by targeting AMPH-1 in non-small-cell lung cancer
Lei Jiang1, Wenyu Ge2, Jingshu Geng1
1Department of Pathology, Harbin Medical University Cancer Hospital, Harbin 150040, China.
Background:
MicroRNAs (miRNAs) have been proved to act as vital roles on non-small-cell lung cancer (NSCLC), and miR-425 has been proven to serve an important function in several tumors. However, the functional role of miR-425 on NSCLC is still unclear.
Methods:
The mRNA and protein expression of miR-425 and AMPH-1 were determined by qRT-PCR and western blot analysis, respectively. NSCLC cells (SK-MES-1 and A549) proliferation and migration were measured by CCK-8 and transwell assay, respectively. Cell apoptosis was assessed by flow cytometry and western blotting, In addition, luciferase reporter assay was carried out to confirm the direct targeting of AMPH-1 by miR-425. Xenograft experiments were performed to observe the tumorigenesis of miR-425 in vivo.
Results:
The results showed that miR-425 was overexpressed and AMPH-1 expression was downregulated in SK-MES-1 and A549 cells. Silencing miR-425 inhibited proliferation, migration and promoted apoptosis of NSCLC cells. Moreover, we proved that miR-425 could target AMPH-1. The expression of AMPH-1was upregulated in A549 with miR-425 inhibitor. Moreover, miR-425 knockdown were less tumorigenic than the control in vivo.
Conclusions:
Taken together, miR-425 could promote the proliferation, invasion and suppress apoptosis by targeting AMPH-1 in NSCLC cells. miR-425/AMPH-1 axis may represent a potential therapeutic strategy or novel prognostic biomarkers to NSCLC.
Insights
MicroRNA-425 (miR-425) promotes non-small-cell lung cancer (NSCLC) progression by targeting AMPH-1. This miR-425/AMPH-1 interaction offers potential therapeutic strategies and prognostic biomarkers for NSCLC patients.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- MicroRNAs (miRNAs) play crucial roles in non-small-cell lung cancer (NSCLC).
- The specific function of miR-425 in NSCLC remains largely uncharacterized.
- miR-425 has demonstrated involvement in the progression of various other tumor types.
Purpose of the Study:
- To elucidate the functional role of miR-425 in NSCLC.
- To investigate the relationship between miR-425 and AMPH-1 in NSCLC.
- To explore the potential of the miR-425/AMPH-1 axis as a therapeutic target or biomarker.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) and western blotting were used to assess miR-425 and AMPH-1 expression.
- Cell proliferation, migration, and apoptosis were evaluated using CCK-8, transwell assays, and flow cytometry.
- Luciferase reporter assays and xenograft experiments were conducted to confirm targeting and in vivo tumorigenesis.
Main Results:
- miR-425 was found to be overexpressed, while AMPH-1 was downregulated in NSCLC cells (SK-MES-1 and A549).
- Silencing miR-425 inhibited NSCLC cell proliferation and migration while promoting apoptosis.
- miR-425 directly targets AMPH-1, and its knockdown reduced tumor formation in vivo.
Conclusions:
- miR-425 promotes NSCLC proliferation and invasion while suppressing apoptosis by targeting AMPH-1.
- The miR-425/AMPH-1 axis presents a promising avenue for novel therapeutic strategies and prognostic biomarkers in NSCLC.
More Related Videos
09:45An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...